Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
J Neuroimmunol
; 361: 577755, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1472063
ABSTRACT
Vaccine administration may be involved in the development of some central nervous system demyelinating diseases. The COVID-19 vaccine is being administered to the entire population, but to date, little association between vaccination and the risk of developing multiple sclerosis (MS) has been suggested, and only a few case reports have been published. Here, we present a 40-year-old woman who developed cervical myelitis after receiving the COVID-19 vaccine. Myelitis was considered the initial clinical manifestation of MS. Our case suggests a possible link between the vaccination and the clinical MS attack.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
/
Vacuna BNT162
/
Esclerosis Múltiple
Tipo de estudio:
Reporte de caso
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
/
Vacunas
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
J Neuroimmunol
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS